Plandaí Biotechnology, Inc.

PLPL

US72703D1000

Investment Holding Companies

Market Closed - OTC Markets Other stock markets 02:14:43 2024-07-12 pm EDT			5-day change	1st Jan Change
0.0002 ^USD	0.00%		-33.33%	0.00%

2023	Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.	CI
2023	Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc	CI

Plandai Biotechnology, Inc. and Dunn Roman Holdings Africa (Proprietary) Ltd Announce $13 Million New Financing from Land and Development Bank of South Africa

January 25, 2012 at 08:30 am EST

Plandai Biotechnology, Inc. announced that the company, through its Dunn Roman Holdings Africa (Proprietary) Ltd, secured loan financing from the Land and Development Bank of South Africa in the amount of $13,000,000 (ZAR 100 million). The company has been notified by the Land Bank that they should anticipate receipt of the first tranche of funding on or about February 25, 2012.

Latest news about Plandaí Biotechnology, Inc.

Plandaí Biotechnology, Inc. cancelled the acquisition of ByoPlanet International, LLC.	23-07-31	CI
Rick O'Shea Steps into the Role as CEO of Plandaí Biotechnology, Inc	23-05-17	CI
Plandaí Biotechnology, Inc. entered into share exchange agreement to acquire ByoPlanet International, LLC.	23-05-16	CI
EV Hotel Corp. terminated the acquisition of Plandaí Biotechnology, Inc. in a reverse merger transaction.	23-01-03	CI
EV Hotel Corp. entered into non-binding letter of intent to acquire Plandaf Biotechnology, Inc. in a reverse merger transaction.	22-10-05	CI
Plandaí Biotechnology, Inc. Addresses Bioavailability and the Science of Phytofare from Previous Human Clinical Trial Results	18-04-10	CI
Plandai Biotechnology Announces Phytofare to Be Focus of Human Clinical Trial for Type II Diabetes in Mauritius	17-05-16	CI
Plandai Biotechnology Executes Exclusive Distribution Agreement with Cambridge Commodoties for UK and All of Europe	17-05-08	CI
Plandaí Biotechnology, Inc. Receives 1.2 Million Origine 8 Capsule Order from Coyne Healthcare	17-05-02	CI
Plandai Biotechnology, Inc Appoints Ezra Jones as Vice President of Sales and Marketing	17-04-28	CI
NutriBullets SuperFood Boost Featuring Plandai Biotechnology's Phytofare Expected to Hit Retailers in May 2017	17-04-24	CI
Plandaí Biotechnology, Inc. Names Callum Cottrell-Duffield as President and Chief Operating Officer	17-03-27	CI
ProText Mobility, Inc. acquired Cannabis Biosciences Inc. from Plandaí Biotechnology, Inc. for $0.12 million.	17-03-26	CI
Plandai Biotechnology Enters Pact in Principal with North West University for New Clinical Trials to Evaluate Effectiveness of Phytofare in Treating Type II Diabetes	16-08-31	CI
Plandaí Biotechnology, Inc. Auditor Raises 'Going Concern' Doubt	16-06-29	CI
Plandai Biotechnology, Inc. to Include Phytofare® Catechin-Propheroid® Formulation in Grain-Based Pellets	16-05-24	CI
Plandai Biotechnology, Inc. Announces VitaminExpress	16-05-10	CI
Plandai Biotechnology, Inc. Announces Sales Results for the Month April 2016	16-04-29	CI
Plandai Biotechnology Signs Distribution Agreement with AIDP	16-04-04	CI
Plandaí Biotechnology, Inc. Announces Management Changes	16-03-02	CI
Plandai Biotechnology, Inc. Announces License Agreement with Coyne Healthcare	16-02-02	CI
Plandai Biotechnology Executes Distribution Agreement with Bal Pharma Ltd Covering India	15-10-27	CI
Ultimate Sports Nutrition Develops New Products Using Phytofare	15-08-26	CI
Plandaí Biotechnology, Inc. Announces Expansion of Agreement with USN to Now Include the European Union	15-08-10	CI
Plandai Biotechnology to Deliver Green Tea Extract to USN	15-07-16	CI

Chart Plandaí Biotechnology, Inc.

Duration

Period

More charts

Company Profile

Plandai Biotechnology, Inc. is a biotech company, which is focused on the production of botanical extracts for the nutraceutical and pharmaceutical industries. The Company grows the green tea used in its products on a 3,000-hectare estate in the Mpumalanga region of South Africa. Its marketed product, Phytofare Catechin Complex, is a green-tea-derived extract that has multiple potential wellness applications. It caters to airline flights and operated coffee shops, lounges and gift shops at airports, and other facilities located in Florida, Alabama, and Georgia. Its airline catering services include the preparation of meals in kitchens located at, or adjacent to, airports and the distribution of meals and beverages for service on commercial airline flights. The Company also provides certain ancillary services, including the preparation of beverage service carts, the unloading and cleaning of plates, utensils and other accessories arriving on incoming aircraft, and other.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
PLANDAÍ BIOTECHNOLOGY, INC.	0.00%	1.78M
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+76.43%	5.87B
CHURCHILL CAPITAL CORP VII	+2.76%	988M
PERELLA WEINBERG PARTNERS	+46.03%	955M
ARES ACQUISITION CORPORATION II	+2.49%	669M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
E7 GROUP	-2.15%	593M
ADMIRAL ACQUISITION LIMITED	+10.28%	536M
CAPITOL INVESTMENT CORP. VII	-.--%	500M
AEA-BRIDGES IMPACT CORP.	-2.10%	470M

Shell Companies

Plandaí Biotechnology, Inc.

Equities

PLPL

US72703D1000

Investment Holding Companies

Plandai Biotechnology, Inc. and Dunn Roman Holdings Africa (Proprietary) Ltd Announce $13 Million New Financing from Land and Development Bank of South Africa

Latest news about Plandaí Biotechnology, Inc.

Chart Plandaí Biotechnology, Inc.

Company Profile

Sector Shell Companies